Sopharma Trading AD (BUL:SFT) said that its board of directors decided to conduct a detailed analysis of potential opportunities to take ownership in companies active in the making or marketing of healthcare products in Serbia. Sopharma will explore the possibility to purchase stakes or equity shares in manufacturers or suppliers in Serbia of medicines, food supplements, medical devices or other health-related products, the Bulgarian company said in a bourse filing. The board has authorised company representatives to evaluate, research and conduct initial negotiations with a view to carrying out a possible acquisition of joint participation and/or a majority share in the capital of companies that fit the target.